Search research articles
Contact Us
Filters
Showing results (31-40 of 153) with videos related to
Page
of 16
Sort By:
JAMA Oncology
|
May 3, 2019
Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
Carole Fakhry, Amanda L Blackford, Geoff Neuner, et al.
The Journal of Infectious Diseases
|
January 20, 2026
Risk-based prophylactic HPV vaccination of heterosexual US men aged 27 to 45 years for prevention of oropharyngeal cancer
Anil K Chaturvedi, Gregory Haber, Barry I Graubard, et al.
Head and Neck Pathology
|
February 25, 2025
Development and Validation of an Assay to Quantify Plasma Circulating Tumor Human Papillomavirus DNA for 13 High-Risk Types that Cause 98% of HPV-Positive Cancers
Michael T Wotman, Weihong Xiao, Robyn R Du, et al.
International Journal of Cancer
|
April 10, 2013
Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix
Maura L Gillison, Xavier Castellsagué, Anil Chaturvedi, et al.
Vaccine
|
December 4, 2012
Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis
Maura L Gillison, Laia Alemany, Peter J F Snijders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2019
Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals
Joseph E Tota, Ana F Best, Zachary S Zumsteg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma
Yuri Agrawal, Wayne M Koch, Weihong Xiao, et al.
Journal of the National Cancer Institute
|
February 14, 2008
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry, William H Westra, Sigui Li, et al.
International Journal of Cancer
|
January 6, 2007
Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor viruses
Maura L Gillison, Renwei Chen, Eleni Goshu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2025
Trastuzumab Deruxtecan in HER2-Low or HER2-Mutant Recurrent/Metastatic Secretory Gland Cancers of the Head and Neck: A Case Series
Michael T Wotman, Alexander Khalaf, Kaiwen Wang, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 153) with videos related to
Sort By:
Page
of 16
JAMA Oncology
|
May 3, 2019
Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
Carole Fakhry, Amanda L Blackford, Geoff Neuner, et al.
The Journal of Infectious Diseases
|
January 20, 2026
Risk-based prophylactic HPV vaccination of heterosexual US men aged 27 to 45 years for prevention of oropharyngeal cancer
Anil K Chaturvedi, Gregory Haber, Barry I Graubard, et al.
Head and Neck Pathology
|
February 25, 2025
Development and Validation of an Assay to Quantify Plasma Circulating Tumor Human Papillomavirus DNA for 13 High-Risk Types that Cause 98% of HPV-Positive Cancers
Michael T Wotman, Weihong Xiao, Robyn R Du, et al.
International Journal of Cancer
|
April 10, 2013
Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix
Maura L Gillison, Xavier Castellsagué, Anil Chaturvedi, et al.
Vaccine
|
December 4, 2012
Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis
Maura L Gillison, Laia Alemany, Peter J F Snijders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2019
Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals
Joseph E Tota, Ana F Best, Zachary S Zumsteg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma
Yuri Agrawal, Wayne M Koch, Weihong Xiao, et al.
Journal of the National Cancer Institute
|
February 14, 2008
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial
Carole Fakhry, William H Westra, Sigui Li, et al.
International Journal of Cancer
|
January 6, 2007
Human retinoblastoma is not caused by known pRb-inactivating human DNA tumor viruses
Maura L Gillison, Renwei Chen, Eleni Goshu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2025
Trastuzumab Deruxtecan in HER2-Low or HER2-Mutant Recurrent/Metastatic Secretory Gland Cancers of the Head and Neck: A Case Series
Michael T Wotman, Alexander Khalaf, Kaiwen Wang, et al.
Page
of 16